BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 30476149)

  • 1. Similarities and differences in the reproductive phenotypes of women with congenital hypogonadotrophic hypogonadism caused by GNRHR mutations and women with polycystic ovary syndrome.
    Maione L; Fèvre A; Nettore IC; Manilall A; Francou B; Trabado S; Bouligand J; Guiochon-Mantel A; Delemer B; Flanagan CA; Macchia PE; Millar RP; Young J
    Hum Reprod; 2019 Jan; 34(1):137-147. PubMed ID: 30476149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of KISS1 Receptor mutations in a series of 603 patients with normosmic congenital hypogonadotrophic hypogonadism and characterization of novel mutations: a single-centre study.
    Francou B; Paul C; Amazit L; Cartes A; Bouvattier C; Albarel F; Maiter D; Chanson P; Trabado S; Brailly-Tabard S; Brue T; Guiochon-Mantel A; Young J; Bouligand J
    Hum Reprod; 2016 Jun; 31(6):1363-74. PubMed ID: 27094476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GnRH stimulation testing and serum inhibin B in males: insufficient specificity for discriminating between congenital hypogonadotropic hypogonadism from constitutional delay of growth and puberty.
    Mosbah H; Bouvattier C; Maione L; Trabado S; De Filippo G; Cartes A; Donzeau A; Chanson P; Brailly-Tabard S; Dwyer AA; Coutant R; Young J
    Hum Reprod; 2020 Oct; 35(10):2312-2322. PubMed ID: 32862222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of ncHH: from a peculiar inheritance of a novel GNRHR mutation to a comprehensive review of the literature.
    Cioppi F; Riera-Escamilla A; Manilall A; Guarducci E; Todisco T; Corona G; Colombo F; Bonomi M; Flanagan CA; Krausz C
    Andrology; 2019 Jan; 7(1):88-101. PubMed ID: 30575316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kisspeptin treatment induces gonadotropic responses and rescues ovulation in a subset of preclinical models and women with polycystic ovary syndrome.
    Romero-Ruiz A; Skorupskaite K; Gaytan F; Torres E; Perdices-Lopez C; Mannaerts BM; Qi S; Leon S; Manfredi-Lozano M; Lopez-Rodriguez C; Avendaño MS; Sanchez-Garrido MA; Vazquez MJ; Pinilla L; van Duin M; Kohout TA; Anderson RA; Tena-Sempere M
    Hum Reprod; 2019 Dec; 34(12):2495-2512. PubMed ID: 31820802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for gonadotrophin secretory and steroidogenic abnormalities in brothers of women with polycystic ovary syndrome.
    Liu DM; Torchen LC; Sung Y; Paparodis R; Legro RS; Grebe SK; Singh RJ; Taylor RL; Dunaif A
    Hum Reprod; 2014 Dec; 29(12):2764-72. PubMed ID: 25336708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular defects of the GnRH-receptor gene in Chinese patients with idiopathic hypogonadotropic hypogonadism and the severity of hypogonadism.
    Fathi AK; Hu S; Fu X; Huang S; Liang Y; Ning Q; Luo X
    J Pediatr Endocrinol Metab; 2012; 25(7-8):659-68. PubMed ID: 23155690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
    Fraissinet A; Robin G; Pigny P; Lefebvre T; Catteau-Jonard S; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1716-1722. PubMed ID: 28854589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study.
    Bell RJ; Islam RM; Skiba MA; Herbert D; Martinez Garcia A; Davis SR
    Hum Reprod; 2021 Dec; 37(1):109-118. PubMed ID: 34741176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
    Alebić MŠ; Stojanović N; Duhamel A; Dewailly D
    Hum Reprod; 2015 Aug; 30(8):1927-33. PubMed ID: 26048913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole Exome Sequencing Revealed a Novel Nonsense Variant in the GNRHR Gene Causing Normosmic Hypogonadotropic Hypogonadism in a Pakistani Family.
    Hussain HMJ; Murtaza G; Jiang X; Khan R; Khan M; Kakakhel MBS; Khan T; Wahab F; Zhang H; Zhang Y; Khan MB; Ahmed P; Ma H; Xu Z
    Horm Res Paediatr; 2019; 91(1):9-16. PubMed ID: 30947225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clustering of PCOS-like traits in naturally hyperandrogenic female rhesus monkeys.
    Abbott DH; Rayome BH; Dumesic DA; Lewis KC; Edwards AK; Wallen K; Wilson ME; Appt SE; Levine JE
    Hum Reprod; 2017 Apr; 32(4):923-936. PubMed ID: 28333238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Müllerian hormone: correlation with testosterone and oligo- or amenorrhoea in female adolescence in a population-based cohort study.
    Pinola P; Morin-Papunen LC; Bloigu A; Puukka K; Ruokonen A; Järvelin MR; Franks S; Tapanainen JS; Lashen H
    Hum Reprod; 2014 Oct; 29(10):2317-25. PubMed ID: 25056088
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Gonçalves CI; Aragüés JM; Bastos M; Barros L; Vicente N; Carvalho D; Lemos MC
    Endocr Connect; 2017 Aug; 6(6):360-366. PubMed ID: 28611058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term changes in hormonal profiles after laparoscopic ovarian laser evaporation compared with diagnostic laparoscopy for PCOS.
    Hendriks ML; König T; Korsen T; Melgers I; Dekker J; Mijatovic V; Schats R; Hompes PG; Homburg R; Kaaijk EM; Twisk JW; Lambalk CB
    Hum Reprod; 2014 Nov; 29(11):2544-52. PubMed ID: 25267790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome.
    Henríquez S; Kohen P; Xu X; Villarroel C; Muñoz A; Godoy A; Strauss JF; Devoto L
    Hum Reprod; 2020 Jul; 35(7):1655-1665. PubMed ID: 32558920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting the distribution of serum anti-müllerian hormone levels among infertile Asian women: a multi-nation, multi-centre, and multi-ethnicity prospective cohort study.
    Tzeng CR; Huang Z; Asada Y; Zhang C; Ho MT; Li RHW; Kim JH; Govindarajan M; Vuyavanich T; Sini I; Wong PS; Singh S; Lin WY; Ho NT
    Hum Reprod; 2023 Jul; 38(7):1368-1378. PubMed ID: 37105234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normosmic congenital hypogonadotropic hypogonadism due to TAC3/TACR3 mutations: characterization of neuroendocrine phenotypes and novel mutations.
    Francou B; Bouligand J; Voican A; Amazit L; Trabado S; Fagart J; Meduri G; Brailly-Tabard S; Chanson P; Lecomte P; Guiochon-Mantel A; Young J
    PLoS One; 2011; 6(10):e25614. PubMed ID: 22031817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle.
    Lockwood GM; Muttukrishna S; Groome NP; Matthews DR; Ledger WL
    J Clin Endocrinol Metab; 1998 May; 83(5):1730-5. PubMed ID: 9589683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.